Henrique Guilherme de Castro Teixeira

Suggest Changes
Learn More
BACKGROUND Tumor necrosis factor (TNF) antagonists have improved outcomes for patients with psoriasis, but some patients are unresponsive to treatment (primary failure) or lose an initially effective(More)
BACKGROUND Adalimumab is an effective treatment for chronic plaque psoriasis. OBJECTIVE To evaluate the safety and efficacy of adalimumab for psoriasis patients who did not adequately respond to(More)
BACKGROUND The PASI score, the most common outcome measure in clinical trials of psoriasis treatment, is a non-linear scale that does not allow reliable assessment of subtle variations of its(More)
BACKGROUND Hidradenitis Suppurativa (HS), also known as acne inversa, is a painful, chronic, debilitating, inflammatory skin disease and has shown response to anti-TNF-α therapy. Efficacy and safety(More)